EPA to Limit Assessments of Toxic Chemical Risks

Reducing the evaluation to only direct contact, rather than including environmental exposures, could leave damaging substances on the market, critics say.

Written byAshley Yeager
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

A chemical found in some shampoos and soaps has been linked to cancer and is under EPA review.ISTOCK, MIHAILULIANIKOVThe chemical industry has successfully lobbied President Donald Trump’s administration to limit the criteria the federal government uses to define chemicals’ risks to safety and health. Documents from the Environmental Protection Agency (EPA) show that the review of chemicals sometimes excludes potential exposures from the air, ground, or water and focuses only on direct contact with the substance, The New York Times reports.

The agency can “better protect human health and the environment by focusing on those pathways that are likely to represent the greatest areas of concern to E.P.A.,” Jahan Wilcox, an agency spokesperson, tells The Times.

Critics, including three former EPA officials, are skeptical of the new approach and say the resulting analyses of chemical threats would be incomplete. “It is ridiculous,” Wendy Cleland-Hamnett, who worked at EPA for nearly 40 years and led the toxic chemical unit before retiring, tells The Times. “You can’t determine if there is an unreasonable risk without doing a comprehensive risk evaluation.”

The less-extensive risk tests run counter to a law passed in June 2016 by then-President Barack Obama that required EPA to review the safety of hundreds of substances—including ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Ashley started at The Scientist in 2018. Before joining the staff, she worked as a freelance editor and writer, a writer at the Simons Foundation, and a web producer at Science News, among other positions. She holds a bachelor’s degree in journalism from the University of Tennessee, Knoxville, and a master’s degree in science writing from MIT. Ashley edits the Scientist to Watch and Profile sections of the magazine and writes news, features, and other stories for both online and print.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies